Protein ? Disassembly im Verlauf der endosomalen Prozessierung

Literatur Seite 170
168 Diment, S.: Different roles for thiol and aspartyl proteases in antigen presentation of ovalbumin; J.
Immunol.145: 417; 1990
169 Hämmerling, G.J. und E. R. Unanue: Antigen Presentation in 1998 and at the 10th International
Congress of Immunology; The Immunologist 7: 19-23; 1999
170 Rappolee, D.A., D. Mark, M.J. Banda, Werb und Z.: Wound macrophages express TGF-a and
other growth factors in vivo: analysis by mRNA phenotyping.; Science 241: 708-712; 1988
171 Barrett, A.J. und J. K. McDonald: Mammalian Proteases: Endoproteases; Academic Press Vol.1;
1980
172 Rao, M., N.M. Wassef, C.R. Alving und Urszula Krzych: Intracellular Processing of Liposome-
Encapsulated Antigens by Macrophages Depends upon the Antigen; Infection and Immunity 63: 2396-
2402; 1995
173 Shenep, J.L., R.P. Barton und K. A. Mogan: Role of antibiotic class in the rate of liberation of
endotoxin during therapy for experimental Gram - negative bacterial sepsis; J. Infect. Dis.151: 1012;
1985
174 Beutler, B. und A. Cerami: Tumor necrosis, cachexia, shock and inflammation: a common
mediator.; Ann. Rev. Biochem.57: 505; 1988
175 Lepay, D.A., R.M. Steinmann, C.F. Nathan, H.W. Murray und Z. A. Cohn: Liver macrophages in
murine listeriosis. Cell mediated immunity is correlated with an influx of macrophages capable of
generating reactive oxygen intermediates.; J. Exp. Med.161: 1503-1512; 1985
176 Pierre, P. und I. Mellman: Developmental regulation of invariant chain proteolysis controls MHC
class II trafficking in mouse dendritic cells.; Cell.93: 1135-45; 1998
177 Rose, S.C., D. Askew, E.H. Noss, A. Tobian, A.M. Krieg und C. V. Harding: CpG
Oligodeoxynucleotides Down-Regulate Macrophage Class II MHC Antigen Processing; J.
Immunol.163: 1188-1194; 1999
178 Steeg, P.S., H.M. Johnson und J. J. Oppenheim: Regulation of murine macrophage Ia antigen
expression by an interferon-like lymphokine: inhibitory effect of endotoxin; J. Immunol.129: 2402;
1982
179 Sicher, S.C., M.A. Vazquez und C. Y. Lu: Inhibition of macrophage Ia expression ny nitric oxide; J.
Immunol.153: 1293; 1994
180 Deussing, J., W. Roth, P. Saftig, Peters, C., H.L. Ploegh und J. A. Villadangos: Cathepsin B
and D are dispensable for major histocompatibility complex class II-mediated antigen presentation;
Proc. Natl. Acad. Sci.95: 4516-4521; 1998
181 Bennett, K., T. Levine, J.S. Ellis, R.J. Peansky, I.M. Samloff, J. Kay und B. M. Chain: Antigen
processing for presentation by class II major histocompatibility complex requires cleavage by
cathepsin E; Eur. J. Immunol.22: 1519-1524; 1992
182 Horwich, A.L., E.U. Weber-Ban und D. Finley: Chaperone rings in protein folding an degradation;
Proc. Natl. Acad. Sci. 96: 11033-11040; 1999
183 Joosten, I., M.H. Wauben, M.C. Holewijn, K. Reske, L.O. Pedersen, C.F. Roosenboom, E.J.
Hensen, E.W. van und S. Buus: Direct binding of autoimmune disease related T cell epitopes to
purified Lewis rat MHC class II molecules.; Int Immunol.6: 751-9; 1994
184 Wauben, M.H., d.K.M. van, S.M.C. Grosfeld und I. Joosten: Definition of an extended MHC class
II-peptide binding motif for the autoimmune disease-associated Lewis rat RT1.BL molecule.; Int
Immunol.9: 281-90; 1997
185 Lafuse, W.P., D. Brown, L. Castle und B. S. Zwilling: IFN-gamma increases cathepsin H mRNA
levels in mouse macrophages; J. Leuk. Biol. 57: 663-669; 1995
186 Rost, B. und C. Sander: Bridging the protein sequence-structure gap by structure predictions; Ann.
Rev. Biophys. Biomol. Struct.25: 113-136; 1996